Dr. Bessy Flores Chang, MD

NPI: 1437563137
Total Payments
$4,485
2024 Payments
$621.62
Companies
15
Transactions
108
Medicare Patients
556
Medicare Billing
$169,447

Payment Breakdown by Category

Food & Beverage$4,485 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,485 108 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,491 25 $0 (2023)
Novo Nordisk Inc $906.94 29 $0 (2024)
Amgen Inc. $688.56 15 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $468.68 13 $0 (2024)
Aurinia Pharma U.S., Inc. $282.16 7 $0 (2023)
GENZYME CORPORATION $120.69 1 $0 (2023)
Otsuka America Pharmaceutical, Inc. $105.16 5 $0 (2024)
Medtronic, Inc. $103.05 1 $0 (2022)
Dynavax Technologies Corporation $73.07 3 $0 (2024)
E.R. Squibb & Sons, L.L.C. $65.49 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $621.62 22 Amgen Inc. ($270.00)
2023 $734.38 22 AstraZeneca Pharmaceuticals LP ($166.82)
2022 $1,463 33 AstraZeneca Pharmaceuticals LP ($473.34)
2021 $1,502 28 AstraZeneca Pharmaceuticals LP ($687.28)
2020 $163.63 3 AstraZeneca Pharmaceuticals LP ($163.63)

All Payment Transactions

108 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
11/15/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $23.98 General
Category: Cardiology
11/01/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $32.59 General
Category: Inflammation/Rare Disease
10/18/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $23.03 General
Category: Obesity
10/15/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $30.31 General
Category: Inflammation/Rare Disease
09/24/2024 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $33.81 General
Category: Hepatitis B Vaccine
08/27/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $23.58 General
Category: Inflammation
08/23/2024 Novo Nordisk Inc Rivfloza (Drug) Food and Beverage In-kind items and services $22.20 General
Category: Rare Disease
08/09/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $34.10 General
Category: Inflammation/Rare Disease
07/13/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $32.94 General
Category: Cardio-renal
06/28/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $22.29 General
Category: Nephrology
06/06/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $124.12 General
Category: Inflammation
05/09/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $7.55 General
Category: Inflammation
04/18/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $28.12 General
Category: Cardio-renal
04/10/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $16.06 General
Category: Diabetes
03/29/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $31.31 General
03/26/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.55 General
Category: Diabetes
03/15/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $17.75 General
Category: Inflammation
03/11/2024 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $19.63 General
Category: Hepatitis B Vaccine
03/11/2024 Dynavax Technologies Corporation Heplisav-B (Drug) Food and Beverage In-kind items and services $19.63 General
Category: Hepatitis B Vaccine
03/08/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $20.13 General
Category: NEPHROLOGY
02/02/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $24.77 General
Category: Cardio-renal
02/02/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.17 General
Category: Diabetes
12/15/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $24.68 General
Category: Cardiovascular and Metabolism
11/15/2023 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $124.12 General
Category: Bone Health
11/10/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.87 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 96 235 $69,709 $18,562
2022 9 196 459 $174,432 $51,942
2021 9 194 548 $231,124 $72,261
2020 4 70 165 $84,099 $26,683
Total Patients
556
Total Services
1,407
Medicare Billing
$169,447
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 35 132 $33,178 $9,537 28.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 22 42 $15,952 $3,554 22.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 25 28 $13,790 $3,335 24.2%
90935 Hemodialysis procedure with physician evaluation Facility 2023 14 33 $6,788 $2,136 31.5%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Facility 2022 11 68 $59,500 $18,432 31.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 54 207 $43,564 $13,691 31.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 21 25 $14,762 $4,622 31.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 23 46 $17,618 $4,106 23.3%
90935 Hemodialysis procedure with physician evaluation Facility 2022 21 43 $9,116 $2,818 30.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 22 22 $10,685 $2,796 26.2%
99284 Emergency department visit for problem of high severity Facility 2022 16 20 $7,455 $2,347 31.5%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 13 13 $6,617 $1,682 25.4%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 15 15 $5,115 $1,447 28.3%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Facility 2021 15 92 $80,500 $25,755 32.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 63 271 $57,013 $18,247 32.0%
90962 Dialysis services (1 physician visit per month), patient 20 years of age and older Facility 2021 15 40 $24,000 $7,684 32.0%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Facility 2021 12 17 $17,986 $5,756 32.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 19 20 $11,560 $3,769 32.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 14 34 $10,256 $3,296 32.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 21 33 $12,870 $3,028 23.5%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 17 23 $11,017 $2,965 26.9%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 18 18 $5,922 $1,760 29.7%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Facility 2020 17 48 $40,224 $12,726 31.6%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Facility 2020 20 36 $25,416 $8,130 32.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 22 70 $14,840 $4,747 32.0%

About Dr. Bessy Flores Chang, MD

Dr. Bessy Flores Chang, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437563137.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bessy Flores Chang, MD has received a total of $4,485 in payments from pharmaceutical and medical device companies, with $621.62 received in 2024. These payments were reported across 108 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($4,485).

As a Medicare-enrolled provider, Flores Chang has provided services to 556 Medicare beneficiaries, totaling 1,407 services with total Medicare billing of $169,447. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

Products in Payments

  • LOKELMA (Drug) $880.15
  • Ozempic (Drug) $703.20
  • Kerendia (Drug) $468.68
  • FARXIGA (Drug) $398.78
  • EVENITY (Biological) $314.80
  • LUPKYNIS (Drug) $282.16
  • TAVNEOS (Drug) $173.00
  • JEVTANA (Drug) $120.69
  • JYNARQUE (Drug) $105.16
  • Aranesp (Biological) $103.76
  • ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $103.05
  • KRYSTEXXA (Biological) $97.00
  • Rybelsus (Drug) $89.16
  • Heplisav-B (Drug) $73.07
  • RYBELSUS (Drug) $69.35
  • ELIQUIS (Drug) $65.49
  • Velphoro (Drug) $47.47
  • Veltassa (Drug) $37.84
  • FUROSCIX (Drug) $23.98
  • Wegovy (Drug) $23.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx